Clinical Trials Directory

Trials / Completed

CompletedNCT03350737

Coronary Arteriogenetic Heparinized Exercise

Coronary ARteriogenesis With Combined Heparin and EXercise Therapy in Chronic Refractory Angina

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Clinical Centre of Serbia · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study evaluates the addition of heparin to a 2-week cycle of physical rehabilitation in the treatment of refractory angina. Half of the patients will undergo heparin-primed physical rehabilitation, while the other half will undergo only physical rehabilitation.

Detailed description

Our approach is based on the combination of pharmacological stimuli (with heparin) on top of a 2-week cycle of physical rehabilitation. The rationale for this chemical-physical cocktail stems from the fact that increase in shear stress (achieved with exercise), or heparin (when used alone) have no significant effect on coronary arteriogenesis. Nevertheless, when the two stimuli are coupled coronary arteriogenesis is consistently present, and clinically significant. The basic principle of heparin treatment is to potentiates angiogenic growth factors, which are over expressed by increased shear stress at the site of pre-existing collateral vessels as a result of exercise or pacing. Although the precise mechanisms by which heparin potentiates arteriogenesis remain to be completely elucidated, heparin administration combined with exercise has great potential in treating patients with effort angina who are not indicated for conventional revascularization therapy.

Conditions

Interventions

TypeNameDescription
OTHERPhysical rehabilitationStandard treadmill exercise session
DRUGHeparinHeparin i.v.
OTHERPlaceboSodium Chloride 0.9% i.v.

Timeline

Start date
2013-02-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2017-11-22
Last updated
2020-05-13

Locations

1 site across 1 country: Serbia

Source: ClinicalTrials.gov record NCT03350737. Inclusion in this directory is not an endorsement.